Opioid Use Disorders and Pregnancy

Amanda J. Johnson; Cresta W. Jones

doi:10.1016/j.ogc.2018.01.008

Opioid Use Disorders and Pregnancy

Amanda J. Johnson, Cresta W. Jones

Obstetrics, Gynecology and Women's Health - Fetal Medicine

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

Opioid use disorder presents an increased risk of complications in pregnancy, particularly when untreated. To optimize outcomes, medication-assisted treatment using methadone or buprenorphine as a part of a comprehensive care model is recommended. Neonatal abstinence syndrome and poor fetal growth remain significant complications of this disorder despite maternal treatment.

Original language	English (US)
Pages (from-to)	201-216
Number of pages	16
Journal	Obstetrics and Gynecology Clinics of North America
Volume	45
Issue number	2
DOIs	https://doi.org/10.1016/j.ogc.2018.01.008
State	Published - Jun 2018

Bibliographical note

Publisher Copyright:
© 2018 Elsevier Inc.

Keywords

Buprenorphine
Methadone
Neonatal abstinence syndrome
Opioid use disorder
Pregnancy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.ogc.2018.01.008

OpenUrl availability

Full text

Cite this

@article{1615709bd14548efb65deb9a84225e5d,

title = "Opioid Use Disorders and Pregnancy",

abstract = "Opioid use disorder presents an increased risk of complications in pregnancy, particularly when untreated. To optimize outcomes, medication-assisted treatment using methadone or buprenorphine as a part of a comprehensive care model is recommended. Neonatal abstinence syndrome and poor fetal growth remain significant complications of this disorder despite maternal treatment.",

keywords = "Buprenorphine, Methadone, Neonatal abstinence syndrome, Opioid use disorder, Pregnancy",

author = "Johnson, {Amanda J.} and Jones, {Cresta W.}",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2018",

month = jun,

doi = "10.1016/j.ogc.2018.01.008",

language = "English (US)",

volume = "45",

pages = "201--216",

journal = "Obstetrics and Gynecology Clinics of North America",

issn = "0889-8545",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Opioid Use Disorders and Pregnancy

AU - Johnson, Amanda J.

AU - Jones, Cresta W.

PY - 2018/6

Y1 - 2018/6

N2 - Opioid use disorder presents an increased risk of complications in pregnancy, particularly when untreated. To optimize outcomes, medication-assisted treatment using methadone or buprenorphine as a part of a comprehensive care model is recommended. Neonatal abstinence syndrome and poor fetal growth remain significant complications of this disorder despite maternal treatment.

AB - Opioid use disorder presents an increased risk of complications in pregnancy, particularly when untreated. To optimize outcomes, medication-assisted treatment using methadone or buprenorphine as a part of a comprehensive care model is recommended. Neonatal abstinence syndrome and poor fetal growth remain significant complications of this disorder despite maternal treatment.

KW - Buprenorphine

KW - Methadone

KW - Neonatal abstinence syndrome

KW - Opioid use disorder

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85043526799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043526799&partnerID=8YFLogxK

U2 - 10.1016/j.ogc.2018.01.008

DO - 10.1016/j.ogc.2018.01.008

M3 - Review article

C2 - 29747726

AN - SCOPUS:85043526799

SN - 0889-8545

VL - 45

SP - 201

EP - 216

JO - Obstetrics and Gynecology Clinics of North America

JF - Obstetrics and Gynecology Clinics of North America

IS - 2

ER -

Opioid Use Disorders and Pregnancy

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this